Real-life quantitative G6PD screening in Plasmodium vivax patients in the Brazilian Amazon: A cost-effectiveness analysis.

Jose Diego Brito-SousaHenry M PeixotoAngela DevineAlexandre V Silva-NetoPatricia C S BalieiroVanderson S SampaioSheila Vitor-SilvaMaxwell O MendesBrenda K A SouzaMarcus V G LacerdaWuelton Marcelo Monteiro

Published in: PLoS neglected tropical diseases (2022)

This cost-effectiveness analysis showed the quantitative G6PD testing was effective in avoiding PQ-associated hospitalizations. The incorporation of G6PD screening is of paramount importance towards P. vivax malaria elimination in the Amazon to promote the safe use of primaquine and tafenoquine.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
mass spectrometry